Clik here to view.
Jivana Biotechnology raises $1m for targeted cancer therapy
Jivana Biotechnology raised $1 million for its preclinical work using targeted RNA-based therapies to treat a variety of cancers, according to a regulatory filing the Oak Park, Ill.-based company...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 26, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Australia pulls GI Dynamics EndoBarrier from the market
GI Dynamics (ASX:GID) said today that Australia’s Therapeutics Goods Administration removed the EndoBarrier weight loss device from the Register of Therapeutic Goods, effectively stopping...
View ArticleClik here to view.
Study shows no benefit for Exogen bone stim from Bioventus
A new study, published yesterday in the BMJ, is casting doubts on the healing benefit of Bioventus‘s Exogen ultrasound bone stimulator. The Durham, N.C.-based company’s Exogen is designed to use...
View ArticleClik here to view.
Perceptive Advisors drums up $323m for debt fund
Health care focused investment management firm Perceptive Advisors said today it closed a new fund, raking in $323 million to support healthcare companies, exceeding its $300 million target. The fund...
View ArticleClik here to view.
Misonix interim CEO Vizirgianakis puts $4m into company
Misonix (NSDQ:MSON) said today its interim CEO Stavros Vizirgianakis invested $4 million into the company through the purchase of 761,469 shares at $5.25 per share. The shares purchased are considered...
View ArticleClik here to view.
Acutus Medical launches AcQMap study
Acutus Medical said today it launched a trial of its AcQMap high resolution imaging and mapping system designed to guide ablation procedures for treating persistent atrial fibrillation. The company’s...
View ArticleClik here to view.
Drug and medical device clinical trials 101
Most medical professionals enjoy being on the forefront of new clinical treatments, techniques and products. Drug and device research trials are a great opportunity for those in the healthcare field to...
View ArticleClik here to view.
Zimmer Biomet picks up tele-rehab provider RespondWell
Zimmer Biomet (NYSE:ZBH) said today that it paid an unspecified amount for tele-rehabilitation provider RespondWell, which it plans to fold into its recently launched Signature Solutions business....
View ArticleClik here to view.
St. Jude Medical’s shareholders OK $25B Abbott buyout
St. Jude Medical (NYSE:STJ) said yesterday that its shareholders voted to approve its pending, $25 billion buyout by Abbott (NYSE:ABT). Preliminary results showed that about 99% of shareholders at the...
View ArticleClik here to view.
Abbott slapped with $4m loss in age discrimination suit
A jury in Puerto Rico yesterday slapped Abbott (NYSE:ABT) with a $4 million loss in an age discrimination lawsuit filed by a former employee there. Luz González Bermúdez sued Abbott and manager Kim...
View ArticleClik here to view.
Nihon Kohden wins $35m patient monitoring deal with US Defense Dept.
The American division of Japan’s Nihon Kohden (TYO:6849) won a Pentagon contract worth more than $35.3 million, the U.S. Defense Dept. said yesterday. The 1-year deal, which has 8 1-year extension...
View ArticleClik here to view.
North America business, cost cuts boost Fresenius
Reuters — Cost cuts, business overhauls and the launch of generic drugs in North America benefited German healthcare group Fresenius (ETR:FRE), which slightly upped its earnings guidance following the...
View ArticleClik here to view.
Titan Medical adds $900k to $8m overnight offering
Titan Medical (TSE:TMD) said today that it brought in another $909,000 after the underwriters of an overnight offering picked up their over-allotment option. Toronto-based Titan said it sold some 2...
View ArticleClik here to view.
3D-printed device controls ultrasound waves for surgical procedures
Researchers from Nanyang Technological University in Singapore developed a 3D-printed device that harnesses high-pressure ultrasound to move, manipulate or destroy tiny objects. By controlling these...
View ArticleClik here to view.
Study: Bypass better than stents for non-compliant patients
(Reuters) — For heart disease patients who adhere to optimal medical therapy, outcomes of coronary bypass graft surgery and percutaneous coronary intervention may not differ, a new study finds....
View ArticleClik here to view.
ResMed CEO Farrell looks to capitalize on M&A
ResMed (NYSE:RMD) CEO Mick Farrell sees light on the horizon for the medical device firm. Farrell spoke to MassDevice at AdvaMed’s annual meeting last week in Minneapolis about the company’s...
View ArticleClik here to view.
Bonesupport raises $37m to support Cerament platform
Bonesupport said today it raised $37 million in anew round of equity and debt financing, with funds slated to support its Cerament platform of products. The oversubscribed equity round was led by...
View ArticleClik here to view.
Engility wins $112m FDA contract for scientific computing
Engility Holdings said today it won a 5-year, $112 million indefinite delivery/indefinite quantity contract with the FDA’s Scientific Computing Board and Office of Information Management and...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 27, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article